It is a trading public limited company based in Lucknow, Uttar Pradesh, India, established in 2017.
2017 | Lucknow, Uttar Pradesh, India | ActiveWasazra Pharmaceuticals Limited, a active public limited company, was established on 01 June 2017 in Lucknow, Uttar Pradesh, India. Engaging in specialty within the trading sector, it holds CIN: U51909UP2017PLC093735. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Sayed Ahmad Masood Hashmi (Managing Director), Firdaus Fatima (Director), Nida Fatima (Director). Past directors included Sayed Ahmad Masood Hashmi, Syed Mohammad Fauzan Akhtar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 628C/30 Sarvodai Nagar, Lucknow, Uttar Pradesh, 226016.
U51909UP2017PLC093735
093735
01 June 2017
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Wasazra Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sayed Ahmad Masood Hashmi | Managing Director | 01 Jun 2017 | Current |
| Firdaus Fatima | Director | 01 Jun 2017 | Current |
| Nida Fatima | Director | 01 Jun 2017 | Current |
| Azra Waseem | Director | 01 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 May 2024 | Past |
| Pramod Abcsdd | Managing Director | 14 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wasazra Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 129.7% increase. The company also saw a substantial improvement in profitability, with a 133.81% increase in profit. The company's net worth Soared by an impressive increase of 33.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Wasazra Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Wasazra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Wasazra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wasazra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Wasazra Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Wasazra Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Sayed Ahmad Masood Hashmi was appointed as a Managing Director was appointed as a Managing Director on 01 Jun 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
Firdaus Fatima was appointed as a Director was appointed as a Director on 01 Jun 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
Nida Fatima was appointed as a Director was appointed as a Director on 01 Jun 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
Progress on Azra Waseem was appointed as a Director was appointed as a Director on 01 Jun 2017 & has been associated with this company since 8 years 6 months . was documented.
The CIN of Wasazra Pharmaceuticals Limited is U51909UP2017PLC093735.
Wasazra Pharmaceuticals Limited is headquartered at 628C/30 Sarvodai Nagar, Lucknow, Uttar Pradesh, 226016.
Wasazra Pharmaceuticals Limited was incorporated on 01 June 2017.
The current directors of Wasazra Pharmaceuticals Limited are
The primary industry of Wasazra Pharmaceuticals Limited is Trading.
Wasazra Pharmaceuticals Limited is unlisted.
The authorized capital of Wasazra Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Wasazra Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX